Correlation Between Northstar Clean and Clarity Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Northstar Clean and Clarity Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Northstar Clean and Clarity Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Northstar Clean Technologies and Clarity Pharmaceuticals, you can compare the effects of market volatilities on Northstar Clean and Clarity Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Northstar Clean with a short position of Clarity Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Northstar Clean and Clarity Pharmaceuticals.

Diversification Opportunities for Northstar Clean and Clarity Pharmaceuticals

-0.89
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Northstar and Clarity is -0.89. Overlapping area represents the amount of risk that can be diversified away by holding Northstar Clean Technologies and Clarity Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clarity Pharmaceuticals and Northstar Clean is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Northstar Clean Technologies are associated (or correlated) with Clarity Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clarity Pharmaceuticals has no effect on the direction of Northstar Clean i.e., Northstar Clean and Clarity Pharmaceuticals go up and down completely randomly.

Pair Corralation between Northstar Clean and Clarity Pharmaceuticals

Assuming the 90 days horizon Northstar Clean Technologies is expected to generate 0.48 times more return on investment than Clarity Pharmaceuticals. However, Northstar Clean Technologies is 2.1 times less risky than Clarity Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. Clarity Pharmaceuticals is currently generating about -0.11 per unit of risk. If you would invest  24.00  in Northstar Clean Technologies on October 23, 2024 and sell it today you would earn a total of  3.00  from holding Northstar Clean Technologies or generate 12.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Northstar Clean Technologies  vs.  Clarity Pharmaceuticals

 Performance 
       Timeline  
Northstar Clean Tech 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Northstar Clean Technologies are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Northstar Clean reported solid returns over the last few months and may actually be approaching a breakup point.
Clarity Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clarity Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Northstar Clean and Clarity Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Northstar Clean and Clarity Pharmaceuticals

The main advantage of trading using opposite Northstar Clean and Clarity Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Northstar Clean position performs unexpectedly, Clarity Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clarity Pharmaceuticals will offset losses from the drop in Clarity Pharmaceuticals' long position.
The idea behind Northstar Clean Technologies and Clarity Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Transaction History
View history of all your transactions and understand their impact on performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets